CD47 and neoplasm: To further understand the functional and transcriptional changes of immune tumor-infiltrating immune cells following combined anti-CD47 and anti-PD-L1 treatment, bulk RNA-seq was performed on the tumor-infiltrating immune cells from each tumor-bearing mouse group.